Malaria epidemiology and anti-malarial drug efficacy in Guinea: a review of clinical and molecular studies
Abstract Malaria is one of the leading causes of mortality and morbidity in Guinea. The entire country is considered at risk of the disease. Transmission occurs all year round with peaks occurring from July through October with Plasmodium falciparum as the primary parasite species. Chloroquine (CQ)...
Main Authors: | Mahamoud Sama Cherif, Prabin Dahal, Abdoul Habib Beavogui, Alexandre Delamou, Eugene Kaman Lama, Alioune Camara, Mamadou Pathe Diallo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12936-021-03809-9 |
Similar Items
-
Efficacy and safety of artesunate–amodiaquine and artemether–lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial
by: Abdoul Habib Beavogui, et al.
Published: (2020-06-01) -
ANTI-MALARIAL DRUG RESISTANCE
by: Yenni Yusuf
Published: (2014-05-01) -
Plasmodium falciparum malarial parasites from Brazil lack artemisinin resistance-associated mutations in the kelch13 gene
by: Francesca Chapadense, et al.
Published: (2019-02-01) -
Review of pyronaridine anti-malarial properties and product characteristics
by: Croft Simon L, et al.
Published: (2012-08-01) -
Flavonoid Versus Artemisinin Anti-malarial Activity in Artemisia annua Whole-Leaf Extracts
by: Tomasz Czechowski, et al.
Published: (2019-07-01)